Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mia Delrieux
Institution:
Institute of Cancer Research
Observed institution:
Institute of Cancer Research
ORCID:
0009-0002-0399-1260
Observed ORCID:
0009-0002-0399-1260
OpenAlex ID:
A5093960592
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
·
Clinical Cancer Research
·
46
Data from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Methods S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S5 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S6 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S3 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Methods S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S4 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S4 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Figure S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Tables S1-S19 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Video S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Video S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Supplementary Video S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer
2024
·
Somaieh Hedayat
, Luciano Cascione
, et al.
Show more works
View as search
Works count:
16
Citation count:
46
H-index:
1
I10-index:
1
Year
Topic
Type